Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alisha Holtzhausen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|October 24, 2014
Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer ImmunotherapyAlisha Holtzhausen, Fei Zhao, Kathy S Evans, et al.
The Journal of Clinical Investigation|May 1, 2018
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune responseEric Ubil, Laura Caskey, Alisha Holtzhausen, et al.
Cancer Immunology Research|July 8, 2024
MerTK Induces Dysfunctional Dendritic Cells by Metabolic ReprogrammingEden Y Zewdie, George M Edwards, Debra M Hunter, et al.
International Journal of Molecular Sciences|July 27, 2024
MERTK Inhibition as a Targeted Novel Cancer TherapyK M Tanim, Alisha Holtzhausen, Aashis Thapa, et al.
Cancers|October 13, 2021
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling AxisBalamayooran Theivanthiran, Tarek Haykal, Linda Cao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 7, 2013
Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and developmentAlisha Holtzhausen, Christelle Golzio, Tam How, et al.
Cancer Immunology Research|June 5, 2015
Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of ImmunotherapyAlisha Holtzhausen, Fei Zhao, Kathy S Evans, et al.
Neoplasia (New York, N.Y.)|August 18, 2011
Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growthCatherine E Gatza, Alisha Holtzhausen, Kellye C Kirkbride, et al.
Cancer Immunology Research|September 14, 2018
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in MelanomaFei Zhao, Kathy Evans, Christine Xiao, et al.
Science Immunology|May 10, 2024
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progressionMichael P Plebanek, Yue Xue, Y-Van Nguyen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 24, 2014
Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer ImmunotherapyAlisha Holtzhausen, Fei Zhao, Kathy S Evans, et al.
The Journal of Clinical Investigation|May 1, 2018
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune responseEric Ubil, Laura Caskey, Alisha Holtzhausen, et al.
Cancer Immunology Research|July 8, 2024
MerTK Induces Dysfunctional Dendritic Cells by Metabolic ReprogrammingEden Y Zewdie, George M Edwards, Debra M Hunter, et al.
International Journal of Molecular Sciences|July 27, 2024
MERTK Inhibition as a Targeted Novel Cancer TherapyK M Tanim, Alisha Holtzhausen, Aashis Thapa, et al.
Cancers|October 13, 2021
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling AxisBalamayooran Theivanthiran, Tarek Haykal, Linda Cao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 7, 2013
Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and developmentAlisha Holtzhausen, Christelle Golzio, Tam How, et al.
Cancer Immunology Research|June 5, 2015
Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of ImmunotherapyAlisha Holtzhausen, Fei Zhao, Kathy S Evans, et al.
Neoplasia (New York, N.Y.)|August 18, 2011
Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growthCatherine E Gatza, Alisha Holtzhausen, Kellye C Kirkbride, et al.
Cancer Immunology Research|September 14, 2018
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in MelanomaFei Zhao, Kathy Evans, Christine Xiao, et al.
Science Immunology|May 10, 2024
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progressionMichael P Plebanek, Yue Xue, Y-Van Nguyen, et al.
Pageof 3